Galamustine

This classification denotes a nitrogen mustard compound with the molecular formula C10H19Cl2NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P771FDQ1WJ, chemically known as d-galactopyranose, 6-(bis(2-chloroethyl)amino)-6-deoxy- but more generally known as galamustine, which bears US NIH Compound Identifier 65891. European Medicines Agency schedules Galamustine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07869MIG. The term GALAMUSTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). GALAMUSTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule galamustine under HS 29329970 and SITC 51569. As of Q4 2014, GALAMUSTINE remains US FDA's Preferred Term for this commodity. Galamustine bears US NLM identifiers UMLS ID C2700228 and NCI Concept Code C76791. SMILES: C(CCL)N(CCCL)CC1C(C(C(C(O1)O)O)O)O.